ARTICLE | Company News
bioMerieux SA, Primagen deal
February 6, 2006 8:00 AM UTC
Primagen granted bioMerieux exclusive rights to the CoV-NL63 coronavirus to develop a diagnostic test. Primagen is eligible for undisclosed milestones and royalties. The virus causes severe respirator...